Skip to main content

2024 ISPE Annual Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Anna-Belle Beau, PhD

Post-doctoral fellow
CERPOP, Inserm U1295, Université de Toulouse Paul Sabatier, Service de Pharmacologie Clinique, CHU de Toulouse, France

Poster(s):

(260) A systematic review of gabapentinoids use during pregnancy and effects on pregnancy and childhood outcomes: an IMI ConcePTION study

Wednesday, August 28, 2024
8:00 AM – 1:30 PM CEST
(275) Gabapentinoids exposure in early pregnancy and risk of congenital anomalies: an IMI ConcePTION European case-malformed control study

Wednesday, August 28, 2024
8:00 AM – 1:30 PM CEST
(282) Reason for gabapentinoids prescribing in pregnancy: results from five European countries. A contribution from the IMI ConcePTION project

Wednesday, August 28, 2024
8:00 AM – 1:30 PM CEST
(310) Risk of congenital ocular anomaly in EUROmediCAT: Assessment of the Potential Risk of Taking Medications during Pregnancy in Europe.

Tuesday, August 27, 2024
8:00 AM – 6:00 PM CEST
(313) Specific congenital anomalies associated with maternal Multiple Sclerosis: A ConcePTION European case-malformed control study

Tuesday, August 27, 2024
8:00 AM – 6:00 PM CEST
(318) The occurrence of specific congenital anomalies associated with maternal Systemic Lupus Erythematosus: A ConcePTION Case-malformed control study in EUROmediCAT

Tuesday, August 27, 2024
8:00 AM – 6:00 PM CEST
(BSPOT37) Identifying women of childbearing age with Multiple Sclerosis in six European healthcare data sources - A contribution from the IMI-ConcePTION project

Tuesday, August 27, 2024
8:00 AM – 6:00 PM CEST